Business Wire

ESI Group and China Automotive Engineering Research Institute Co., Ltd. join forces on Intelligent Simulation

Share

Regulatory News:

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20241217795172/en/

ESI Group (Paris:ESI) and the China Automotive Engineering Research Institute Co. Ltd. (CAERI) have launched a partnership to advance intelligent simulation technology for the automotive industry. This collaboration, marked by the establishment of the Intelligent Simulation Center of Excellence in Chongqing (China), was celebrated with a ceremony attended by Jianwen Zhou, General Manager of the Testing Business Department at CAERI, Guojie Wang, Deputy Director of the Safety Center of the Testing Business Department at CAERI, Qingjiang Zhao, Deputy Director of the Safety Center of the Testing Business Department at CAERI, Corinne Romefort-Régnier, Senior Vice-President, General Secretary & Governance at ESI Group, and Kin-Choong Chan, General Manager at ESI Group’s Asia Pacific region.

The partnership will focus on co-developing cutting-edge virtual simulation solutions tailored to China’s evolving automotive sector while exploring international opportunities. By combining ESI Group’s global expertise and CAERI’s industry leadership, this initiative promises to enhance efficiency, safety, and sustainability across the automotive value chain.

“This partnership signifies a new chapter in automotive simulation,” said Corinne Romefort-Régnier, Senior Vice-President, General Secretary & Governance at ESI Group. “Together, we can deliver groundbreaking solutions that address the needs of the industry and support its transition toward a more sustainable future.”

Jianwen Zhou, General Manager of the Testing Business Department at CAERI, added: “This is a milestone collaboration that will contribute to the development of the automotive industry by leveraging the Center of Excellence for Intelligent Simulation to create innovative solutions in the field of intelligent simulation for customers in China and around the world.”

With the Intelligent Simulation Center of Excellence as its cornerstone, this partnership is set to accelerate innovation and strengthen the industry’s digital transformation on a global scale.

About ESI Group

ESI Group, a part of Keysight Technologies, provides reliable and customized solutions anchored on predictive physics modeling and virtual prototyping expertise. Acting principally in automotive, land transportation, aerospace and defense, and heavy industry, ESI software enables engineers to simulate mechanical designs, smart manufacturing processes, and human-centric workflows to make better decisions earlier in the product lifecycle. Keysight is an S&P 500 company delivering market-leading design, emulation, and test solutions to help engineers develop and deploy faster, with less risk, throughout the entire product lifecycle. For further information, go to: www.esi-group.com

Follow ESILinkedIn | Facebook | Twitter | YouTube

About CAERI

CAERI is subordinated to the China Certification and Inspection Group. As a central state-owned enterprise holding a listed company, it actively fulfills its responsibilities and has received accolades as a “Science and Technology Innovation Demonstrative Enterprise” and a “Benchmark Enterprise.” As a national-level research institute, CAERI is authorized by the Ministry of Industry and Information Technology, the Ministry of Ecology and Environment, the State Administration for Market Regulation, and the Ministry of Transport for automotive product announcements, environmental protection, China Compulsory Certification (CCC), and fuel consumption testing. It houses national-level platforms such as the National Gas Vehicle Engineering Research Center, the National Key Laboratory of Automotive Noise, Vibration, and Safety Technology, the National and Local Joint Engineering Laboratory for Alternative Fuel Vehicles, the National Intelligent Clean Energy Vehicle Quality Inspection and Testing Center, the National Robot Testing and Evaluation Center (Chongqing), the National Motor Vehicle Quality Inspection and Testing Center (Chongqing), the National Hydrogen Power Quality Inspection and Testing Center, and the National Motor Vehicle Quality Inspection and Testing Center (Guangdong). CAERI serves as a crucial base and technical support institution for product development, experimental research, and quality testing in China's automotive industry.

View source version on businesswire.com: https://www.businesswire.com/news/home/20241217795172/en/

Contacts

ESI Group
Emilie Lieblich
press@esi-group.com
+33 1 41 73 58 32

Aline Besselièvre
ext-Aline.Besselievre@esi-group.com
+33 6 61 85 10 05

(c) 2024 Business Wire, Inc., All rights reserved.

Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Align Partners Sends Second Public Shareholder Letter to Coway, Urging Announcement of Revised Value-up Plan by January 30, 202615.12.2025 15:54:00 CET | Press Release

Align Partners Capital Management Inc. (“Align Partners”), a shareholder of Coway Co., Ltd. (“Coway”) since 2023 holding more than 4% of the Company’s outstanding shares through funds it manages or advises, announced that it has sent a second public shareholder letter to Coway’s Board of Directors. The letter calls for measures to address the company’s chronic undervaluation and enhance shareholder value. Align Partners has requested that Coway announce a revised corporate Value-up Plan reflecting these proposals by January 30, 2026. In the letter, Align Partners assessed Coway’s February 2025 plan as insufficient to address Coway’s persistent undervaluation and urged the Board to incorporate seven measures: (1) clear mid-to-long-term valuation and ROE targets with execution plans; (2) clarified and strengthened target capital structure policy; (3) updated shareholder return policy reflecting both the target capital structure policy and new dividend income tax separation regime; (4) en

Marathon Asset Management Provides Junior Capital Financing to EXALTA Group15.12.2025 15:00:00 CET | Press Release

Marathon Asset Management (“Marathon”), a leading global credit manager with more than $24 billion of assets under management, is pleased to announce the closing of a junior capital financing to EXALTA Group (“EXALTA” or the “Company”), a portfolio company of Montagu. Marathon led the financing that supported the formation of EXALTA through the strategic merger of three Montagu-owned companies including Intech, Resolve Surgical Technologies, and Tyber Medical. The transaction marks one of many successful transactions for Marathon’s European Credit business in the healthcare sector, where the firm has a knowledge-based advantage with a dedicated Healthcare Finance business and specialized medical advisory board providing sector insight to middle market companies. EXALTA is a global leader in orthopaedic contract design and manufacturing for spine, trauma, extremities, sports medicine and enabling technology providing comprehensive solutions to OEMs within the medical technology industry

Aurobay Technologies Expands Digital Transformation Partnership With HCLTech to Boost Manufacturing Excellence and Innovation15.12.2025 14:29:00 CET | Press Release

HCLTech, a leading global technology company, and Aurobay Technologies, a division of Horse Powertrain and a global leader in hybrid and low-emission powertrain solutions, have expanded their digital transformation partnership to support Aurobay’s global growth strategy. The expanded partnership establishes HCLTech as Aurobay Technologies’ trusted partner for managing and optimizing SAP, Siemens Teamcenter PLM software and integration services in Sweden and China. This will unlock cost efficiency, operational resilience and digital innovation across Aurobay’s manufacturing and engineering functions by leveraging HCLTech’s flagship service transformation platform, AI Force. The engagement spans core business functions including SAP operations, engineering systems, integration services and mainframe environments, reinforcing Aurobay’s focus on scale, efficiency and seamless operations across global locations. “Horse Powertrain’s division Aurobay Technologies’ digital transformation conti

Applications Now Open for the 5th Cycle of the Mohammed bin Rashid Al Maktoum Global Water Award15.12.2025 14:28:00 CET | Press Release

HE Saeed Mohammed Al Tayer, Chairman of the Board of Trustees of the UAE Water Aid Foundation (Suqia UAE), announced the opening of applications for the 5th cycle of the Mohammed bin Rashid Al Maktoum Global Water Award, offering USD 1 million in prizes. The award seeks to inspire innovative, clean energy–powered solutions for water production, distribution, storage, desalination and purification, supporting global sustainability efforts. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251215897854/en/ HE Saeed Mohammed Al Tayer, Chairman of the Board of Trustees of the UAE Water Aid Foundation (Suqia UAE) - (Photo: AETOSWire) “Since its establishment, Suqia UAE, launched by His Highness Sheikh Mohammed bin Rashid Al Maktoum, Vice President and Prime Minister of the UAE and Ruler of Dubai, has provided clean water to nearly 15 million people in 37 countries worldwide through sustainable development and humanitarian projects.

Novotech Issues White Paper to Help Sponsors Strengthen Early-Phase Oncology Strategy and Execution15.12.2025 14:05:00 CET | Press Release

Novotech, a leading global full-service clinical research organization (CRO) and scientific advisory company, has released a new white paper, Early-Phase Oncology – Clinical Research Landscape and CRO Enablers (2025), offering in-depth analysis of the key drivers shaping early-phase oncology development. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251215843975/en/ With approximately 60% of oncology agents progressing from Phase I to Phase II, but only 3–6% reaching regulatory approval, the paper outlines the factors influencing early-stage success, including trial design, patient selection, and regional development pathways. The paper highlights Australia’s continued position as a global first-in-human (FIH) and early-phase research hub. Its ethics-led review frameworks, which can support trial initiation within roughly 4–8 weeks, combined with established FIH centers, oncology networks, and cost efficiencies, position Au

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye